Tilray Brands, Inc. Operating Expenses
Tilray Brands, Inc. (TLRY) reported Operating Expenses of $323.47 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-07-28
- Tilray Brands, Inc. operating expenses for the quarter ending 2026-05-31 was $106.97M, a 92.92% decline year-over-year.
- Tilray Brands, Inc. operating expenses for the quarter ending 2026-02-28 was $81.34M, a 89.98% decline year-over-year.
- Tilray Brands, Inc. operating expenses for the quarter ending 2025-11-30 was $79.78M, a 22.88% decline year-over-year.
- Tilray Brands, Inc. operating expenses for the quarter ending 2025-08-31 was $55.38M, a 42.48% decline year-over-year.
- Tilray Brands, Inc. operating expenses for fiscal 2026 was $323.47M, a 87.18% decline from fiscal 2025.
- Tilray Brands, Inc. operating expenses for fiscal 2025 was $2.52B, a 533.84% increase from fiscal 2024.
- Tilray Brands, Inc. operating expenses for fiscal 2024 was $398.10M, a 73.75% decline from fiscal 2023.
- Tilray Brands, Inc. operating expenses for fiscal 2023 was $1.52B, a 108.55% increase from fiscal 2022.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|
| 2026-05-31 | $106.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $188.31M derived: sum of 2 quarters · filed 2026-07-28 | $268.09M derived: sum of 3 quarters · filed 2026-07-28 | $323.47M 10-K · filed 2026-07-28 | ||
| 2026-02-28 | $81.34M 10-Q · filed 2026-04-01 | $161.12M derived: sum of 2 quarters · filed 2026-04-01 | $216.49M 10-Q · filed 2026-04-01 | $1.73B derived: sum of 4 quarters · filed 2026-07-28 | ||
| 2025-11-30 | $79.78M 10-Q · filed 2026-01-08 | $135.15M 10-Q · filed 2026-01-08 | $1.65B derived: sum of 3 quarters · filed 2026-07-28 | $2.46B derived: sum of 4 quarters · filed 2026-07-28 | ||
| 2025-08-31 | $55.38M 10-Q · filed 2025-10-09 | $1.57B derived: sum of 2 quarters · filed 2026-07-28 | $2.38B derived: sum of 3 quarters · filed 2026-07-28 | $2.48B derived: sum of 4 quarters · filed 2026-07-28 | ||
| 2025-05-31 | $1.51B derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $2.32B derived: sum of 2 quarters · filed 2026-07-28 | $2.43B derived: sum of 3 quarters · filed 2026-07-28 | $2.52B 10-K · filed 2026-07-28 | ||
| 2025-02-28 | $811.94M 10-Q · filed 2026-04-01 | $915.38M derived: sum of 2 quarters · filed 2026-04-01 | $1.01B 10-Q · filed 2026-04-01 | $1.11B derived: sum of 4 quarters · filed 2026-07-28 | ||
| 2024-11-30 | $103.44M 10-Q · filed 2026-01-08 | $199.71M 10-Q · filed 2026-01-08 | $298.59M derived: sum of 3 quarters · filed 2026-07-28 | $430.08M derived: sum of 4 quarters · filed 2026-07-28 | ||
| 2024-08-31 | $96.28M 10-Q · filed 2025-10-09 | $195.15M derived: sum of 2 quarters · filed 2026-07-28 | $326.65M derived: sum of 3 quarters · filed 2026-07-28 | $415.81M derived: sum of 4 quarters · filed 2026-07-28 | ||
| 2024-05-31 | $98.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $230.37M derived: sum of 2 quarters · filed 2026-07-28 | $319.54M derived: sum of 3 quarters · filed 2026-07-28 | $398.10M 10-K · filed 2026-07-28 | ||
| 2024-02-29 | $131.49M 10-Q · filed 2025-04-08 | $220.66M derived: sum of 2 quarters · filed 2025-04-08 | $299.22M 10-Q · filed 2025-04-08 | $456.36M derived: sum of 4 quarters · filed 2025-07-29 | ||
| 2023-11-30 | $89.17M 10-Q · filed 2025-01-10 | $167.73M 10-Q · filed 2025-01-10 | $324.87M derived: sum of 3 quarters · filed 2025-07-29 | $1.52B derived: sum of 4 quarters · filed 2025-07-29 | ||
| 2023-08-31 | $78.56M 10-Q · filed 2024-10-10 | $235.70M derived: sum of 2 quarters · filed 2025-07-29 | $1.43B derived: sum of 3 quarters · filed 2025-07-29 | $1.53B derived: sum of 4 quarters · filed 2025-07-29 | ||
| 2023-05-31 | $157.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $1.35B derived: sum of 2 quarters · filed 2025-07-29 | $1.45B derived: sum of 3 quarters · filed 2025-07-29 | $1.52B 10-K · filed 2025-07-29 | ||
| 2023-02-28 | $1.20B 10-Q · filed 2024-04-09 | $1.29B derived: sum of 2 quarters · filed 2024-04-09 | $1.36B 10-Q · filed 2024-04-09 | $1.82B derived: sum of 4 quarters · filed 2024-10-10 | ||
| 2022-11-30 | $94.67M 10-Q · filed 2024-01-09 | $91.92M 10-Q · filed 2023-01-09 | $164.47M 10-Q · filed 2024-01-09 | $161.71M 10-Q · filed 2023-01-09 | $625.15M derived: sum of 3 quarters · filed 2024-10-10 | $683.06M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-08-31 | $69.79M 10-Q · filed 2024-10-10 | $530.48M derived: sum of 2 quarters · filed 2024-10-10 | $588.39M derived: sum of 3 quarters · filed 2024-10-10 | $676.69M derived: sum of 4 quarters · filed 2024-10-10 | ||
| 2022-05-31 | $460.69M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $518.60M derived: sum of 2 quarters · filed 2024-07-30 | $606.89M derived: sum of 3 quarters · filed 2024-07-30 | $727.22M 10-K · filed 2024-07-30 | ||
| 2022-02-28 | $57.91M 10-Q · filed 2023-04-10 | $59.59M 10-Q · filed 2022-04-06 | $146.20M derived: sum of 2 quarters · filed 2023-04-10 | $266.53M 10-Q · filed 2023-04-10 | $362.71M derived: sum of 4 quarters · filed 2023-07-26 | |
| 2021-11-30 | $88.30M 10-Q · filed 2023-01-09 | $87.45M 10-Q · filed 2022-01-10 | $208.62M 10-Q · filed 2023-01-09 | $206.94M 10-Q · filed 2022-01-10 | $304.80M derived: sum of 3 quarters · filed 2023-07-26 | $359.31M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-08-31 | $120.32M 10-Q · filed 2022-10-07 | $119.49M 10-Q · filed 2021-10-07 | $216.51M derived: sum of 2 quarters · filed 2023-07-26 | $271.01M derived: sum of 3 quarters · filed 2023-07-26 | $332.26M derived: sum of 4 quarters · filed 2023-07-26 | |
| 2021-05-31 | $96.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $150.69M derived: sum of 2 quarters · filed 2023-07-26 | $211.93M derived: sum of 3 quarters · filed 2023-07-26 | $255.35M 10-K · filed 2023-07-26 | ||
| 2021-02-28 | $54.51M 10-Q · filed 2022-04-06 | $115.75M derived: sum of 2 quarters · filed 2022-04-06 | $159.17M 10-Q · filed 2022-04-06 | |||
| 2020-11-30 | $61.24M 10-Q · filed 2022-01-10 | $104.66M 10-Q · filed 2022-01-10 | ||||
| 2020-08-31 | $43.42M 10-Q · filed 2021-10-07 | |||||
| 2020-05-31 | $200.06M 10-K · filed 2022-07-28 | |||||
| 2019-05-31 | $182.44M 10-K · filed 2021-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |